Hepatitis C virus (HCV) Testing Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2030

Description

Persistence Market Research has recently published a comprehensive report on the global Hepatitis C Virus (HCV) Testing Market, offering a thorough analysis of the key market dynamics, including drivers, trends, opportunities, and challenges. This report provides a detailed insight into the market's structure, highlighting the factors influencing its growth and future projections.

Key Insights:

HCV Testing Market Size (2024E): US$845.0 Mn
Projected Market Value (2030F): US$1185.2 Mn
Global Market Growth Rate (CAGR 2024 to 2030): 5.8%

Hepatitis C Virus Testing Market - Report Scope:

The Hepatitis C Virus (HCV) Testing Market encompasses a wide range of diagnostic tests and procedures used to detect and monitor the presence of the Hepatitis C virus in the human body. These tests play a critical role in early diagnosis, helping healthcare professionals initiate timely treatment, which is essential to preventing liver complications and improving patient outcomes. The market includes various testing methods such as antibody tests, HCV RNA tests, and genotyping assays. Growth in the market is driven by rising prevalence rates of Hepatitis C, increasing awareness about early diagnosis, and the expansion of healthcare infrastructure across developing regions.

Market Growth Drivers:

The global HCV Testing Market is experiencing robust growth, driven primarily by the rising prevalence of Hepatitis C infections, with an estimated 58 million people affected worldwide, as reported by the World Health Organization. This increase is fueled by factors such as needle sharing, unsafe medical practices, and inadequate sanitation in some regions. Technological advancements in diagnostic testing, including point-of-care (POC) tests, have significantly enhanced the accuracy and speed of HCV diagnosis, especially in remote areas. Additionally, government initiatives and public health campaigns aimed at eradicating Hepatitis C, coupled with the development of highly effective direct-acting antiviral (DAA) treatments, have bolstered the demand for early detection and testing. Furthermore, ongoing research and development have introduced more affordable and accessible testing methods, expanding market reach, particularly in lower-income regions.

Market Restraints:

Despite the promising growth trajectory, the HCV Testing Market faces several challenges that could hinder its expansion. A major restraint is the high cost of advanced diagnostic tests, limiting access in developing regions. While basic antibody tests are affordable, sophisticated tests like HCV RNA and genotyping assays are expensive, restricting widespread adoption, especially in areas with limited healthcare budgets. Additionally, a lack of awareness about the importance of early diagnosis hampers timely detection, as many infected individuals remain asymptomatic for years. The complexity of the disease, with its multiple genotypes and subtypes requiring varied treatment approaches, further complicates diagnosis and care, particularly in regions with underdeveloped healthcare infrastructure.

Market Opportunities:

The HCV Testing Market offers substantial growth potential, fueled by advances in diagnostic technologies and the increasing emphasis on preventive healthcare. Innovations such as rapid diagnostic tests (RDTs) are addressing the demand for point-of-care testing, especially in rural areas, by delivering quick results without the need for extensive lab equipment. E-commerce and digital health platforms are also driving growth, enabling easier access to testing services, including home-based kits that offer convenience and privacy. Additionally, the market is poised to benefit from the rise of personalized medicine, as genotyping tests become more crucial for customized treatment plans, improving patient outcomes and reducing long-term healthcare costs.

Key Questions Answered in the Report:

What are the primary factors driving the growth of the Hepatitis C Virus Testing Market globally?
Which types of tests are leading the market, and how are they influencing patient outcomes?
How are technological advancements in diagnostics shaping the competitive landscape of the HCV Testing Market?
Who are the key players in the HCV Testing Market, and what strategies are they employing to maintain their competitive edge?
What are the emerging trends and future prospects in the global HCV Testing Market?

Competitive Intelligence and Business Strategy:

Leading players in the global HCV Testing Market, including Roche Diagnostics, Abbott Laboratories, and Siemens Healthineers, are focusing on innovation, product differentiation, and strategic collaborations to maintain a competitive edge. These companies are investing heavily in research and development to introduce next-generation testing solutions that offer improved accuracy, speed, and affordability. Collaborations with healthcare providers and public health organizations are essential for expanding access to testing in underserved regions, particularly in low- and middle-income countries.

In addition to product innovation, companies are increasingly focusing on patient education and awareness campaigns. By working closely with healthcare professionals and patient advocacy groups, leading market players are helping to raise awareness about the importance of early testing and treatment for Hepatitis C. This approach is expected to not only drive market growth but also improve public health outcomes by ensuring that more individuals are diagnosed and treated at an early stage of the disease.

Key Companies Profiled:

OraSure Technologies, Inc.
Abbott Laboratories Inc.
Siemens Healthcare GmbH
Bio Rad Laboratories Inc.
Ortho Clinical Diagnostic Inc. (Johnson & Johnson)
Bayer AG
QIAGEN N.V.
Thermo Fisher Scientific Inc.
BioGenex
AccuQuick,
Roche Diagnostics (F. Hoffman-La Roche Ltd.)
STD Rapid Test Kits

Hepatitis C Virus Testing Market Industry Segmentation:

By Technique:

Immunoassays-based Hepatitis C Virus Testing
Polymerase Chain Reaction-based (PCR) Hepatitis C Virus Testing
Other Hepatitis C Virus Testing Techniques

By Test Type:

HCV Antibody Testing
HCV Viral Load Testing
HCV Genotyping Testing

By End User:

Hospitals
Diagnostic Centers
Blood Donation Centers

By Region:

North America
Europe
East Asia
South Asia & Oceania
Latin America
Middle East & Africa

Product Code: PMRREP33718

1. Executive Summary

1.1. Global Hepatitis C Virus (HCV) Testing Market Snapshot, 2024-2030
1.2. Market Opportunity Assessment, 2024-2030, US$ Mn
1.3. Key Market Trends
1.4. Future Market Projections
1.5. Premium Market Insights
1.6. Industry Developments and Key Market Events
1.7. PMR Analysis and Recommendations

2. Market Overview

2.1. Market Scope and Definition
2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Opportunity
- 2.2.4. Challenges
- 2.2.5. Key Trends
2.3. Technique Lifecycle Analysis
2.4. Hepatitis C Virus (HCV) Testing Market: Value Chain
- 2.4.1. List of Raw Material Supplier
- 2.4.2. List of Manufacturers
- 2.4.3. List of Distributors
- 2.4.4. List of Applications
- 2.4.5. Profitability Analysis
2.5. Porter Five Force's Analysis
2.6. Geopolitical Tensions: Market Impact
2.7. Macro-Economic Factors
- 2.7.1. Global Sectorial Outlook
- 2.7.2. Global GDP Growth Outlook
- 2.7.3. Global Parent Market Overview
2.8. Forecast Factors - Relevance and Impact
2.9. Regulatory and Technology Landscape

3. Global Hepatitis C Virus (HCV) Testing Market Outlook: Historical (2019-2023) and Forecast (2024-2030)

3.1. Key Highlights
- 3.1.1. Market Volume (Units) Projections
- 3.1.2. Market Size and Y-o-Y Growth
- 3.1.3. Absolute $ Opportunity
3.2. Market Size (US$ Mn) Analysis and Forecast
- 3.2.1. Historical Market Size Analysis, 2019-2023
- 3.2.2. Current Market Size Forecast, 2019-2023
3.3. Global Hepatitis C Virus (HCV) Testing Market Outlook: Technique
- 3.3.1. Introduction / Key Findings
- 3.3.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Technique, 2019-2023
- 3.3.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Technique, 2024-2030
  - 3.3.3.1. Immunoassays-based Hepatitis C Virus Testing
  - 3.3.3.2. Polymerase Chain Reaction-based (PCR) Hepatitis C Virus Testing
  - 3.3.3.3. Other Hepatitis C Virus Testing Techniques
3.4. Market Attractiveness Analysis: Technique
3.5. Global Hepatitis C Virus (HCV) Testing Market Outlook: Test Type
- 3.5.1. Introduction / Key Findings
- 3.5.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Test Type, 2019-2023
- 3.5.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Test Type, 2024-2030
  - 3.5.3.1. HCV Antibody Testing
  - 3.5.3.2. HCV Viral Load Testing
  - 3.5.3.3. HCV Genotyping Testing
3.6. Market Attractiveness Analysis: Test Type
3.7. Global Hepatitis C Virus (HCV) Testing Market Outlook: End User
- 3.7.1. Introduction / Key Findings
- 3.7.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By End User, 2019-2023
- 3.7.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2024-2030
  - 3.7.3.1. Hospitals
  - 3.7.3.2. Diagnostic Centers
  - 3.7.3.3. Blood Donation Centers
3.8. Market Attractiveness Analysis: End User

4. Global Hepatitis C Virus (HCV) Testing Market Outlook: Region

4.1. Key Highlights
4.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Region, 2019-2023
4.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Region, 2024-2030
- 4.3.1. North America
- 4.3.2. Europe
- 4.3.3. East Asia
- 4.3.4. South Asia and Oceania
- 4.3.5. Latin America
- 4.3.6. Middle East & Africa (MEA)
4.4. Market Attractiveness Analysis: Region

5. North America Hepatitis C Virus (HCV) Testing Market Outlook: Historical (2019-2023) and Forecast (2024-2030)

5.1. Key Highlights
5.2. Pricing Analysis
5.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2019-2023
- 5.3.1. By Country
- 5.3.2. By Technique
- 5.3.3. By Test Type
- 5.3.4. By End User
5.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2024-2030
- 5.4.1. U.S.
- 5.4.2. Canada
5.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Technique, 2024-2030
- 5.5.1. Immunoassays-based Hepatitis C Virus Testing
- 5.5.2. Polymerase Chain Reaction-based (PCR) Hepatitis C Virus Testing
- 5.5.3. Other Hepatitis C Virus Testing Techniques
5.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Test Type, 2024-2030
- 5.6.1. HCV Antibody Testing
- 5.6.2. HCV Viral Load Testing
- 5.6.3. HCV Genotyping Testing
5.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2024-2030
- 5.7.1. Hospitals
- 5.7.2. Diagnostic Centers
- 5.7.3. Blood Donation Centers
5.8. Market Attractiveness Analysis

6. Europe Hepatitis C Virus (HCV) Testing Market Outlook: Historical (2019-2023) and Forecast (2024-2030)

6.1. Key Highlights
6.2. Pricing Analysis
6.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2019-2023
- 6.3.1. By Country
- 6.3.2. By Technique
- 6.3.3. By Test Type
- 6.3.4. By End User
6.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2024-2030
- 6.4.1. Germany
- 6.4.2. France
- 6.4.3. U.K.
- 6.4.4. Italy
- 6.4.5. Spain
- 6.4.6. Russia
- 6.4.7. Turkey
- 6.4.8. Rest of Europe
6.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Technique, 2024-2030
- 6.5.1. Immunoassays-based Hepatitis C Virus Testing
- 6.5.2. Polymerase Chain Reaction-based (PCR) Hepatitis C Virus Testing
- 6.5.3. Other Hepatitis C Virus Testing Techniques
6.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Test Type, 2024-2030
- 6.6.1. HCV Antibody Testing
- 6.6.2. HCV Viral Load Testing
- 6.6.3. HCV Genotyping Testing
6.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2024-2030
- 6.7.1. Hospitals
- 6.7.2. Diagnostic Centers
- 6.7.3. Blood Donation Centers
6.8. Market Attractiveness Analysis

7. East Asia Hepatitis C Virus (HCV) Testing Market Outlook: Historical (2019-2023) and Forecast (2024-2030)

7.1. Key Highlights
7.2. Pricing Analysis
7.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2019-2023
- 7.3.1. By Country
- 7.3.2. By Technique
- 7.3.3. By Test Type
- 7.3.4. By End User
7.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2024-2030
- 7.4.1. China
- 7.4.2. Japan
- 7.4.3. South Korea
7.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Technique, 2024-2030
- 7.5.1. Immunoassays-based Hepatitis C Virus Testing
- 7.5.2. Polymerase Chain Reaction-based (PCR) Hepatitis C Virus Testing
- 7.5.3. Other Hepatitis C Virus Testing Techniques
7.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Test Type, 2024-2030
- 7.6.1. HCV Antibody Testing
- 7.6.2. HCV Viral Load Testing
- 7.6.3. HCV Genotyping Testing
7.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2024-2030
- 7.7.1. Hospitals
- 7.7.2. Diagnostic Centers
- 7.7.3. Blood Donation Centers
7.8. Market Attractiveness Analysis

8. South Asia & Oceania Hepatitis C Virus (HCV) Testing Market Outlook: Historical (2019-2023) and Forecast (2024-2030)

8.1. Key Highlights
8.2. Pricing Analysis
8.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2019-2023
- 8.3.1. By Country
- 8.3.2. By Technique
- 8.3.3. By Test Type
- 8.3.4. By End User
8.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2024-2030
- 8.4.1. India
- 8.4.2. Southeast Asia
- 8.4.3. ANZ
- 8.4.4. Rest of South Asia & Oceania
8.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Technique, 2024-2030
- 8.5.1. Immunoassays-based Hepatitis C Virus Testing
- 8.5.2. Polymerase Chain Reaction-based (PCR) Hepatitis C Virus Testing
- 8.5.3. Other Hepatitis C Virus Testing Techniques
8.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Test Type, 2024-2030
- 8.6.1. HCV Antibody Testing
- 8.6.2. HCV Viral Load Testing
- 8.6.3. HCV Genotyping Testing
8.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2024-2030
- 8.7.1. Hospitals
- 8.7.2. Diagnostic Centers
- 8.7.3. Blood Donation Centers
8.8. Market Attractiveness Analysis

9. Latin America Hepatitis C Virus (HCV) Testing Market Outlook: Historical (2019-2023) and Forecast (2024-2030)

9.1. Key Highlights
9.2. Pricing Analysis
9.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2019-2023
- 9.3.1. By Country
- 9.3.2. By Technique
- 9.3.3. By Test Type
- 9.3.4. By End User
9.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2024-2030
- 9.4.1. Brazil
- 9.4.2. Mexico
- 9.4.3. Rest of Latin America
9.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Technique, 2024-2030
- 9.5.1. Immunoassays-based Hepatitis C Virus Testing
- 9.5.2. Polymerase Chain Reaction-based (PCR) Hepatitis C Virus Testing
- 9.5.3. Other Hepatitis C Virus Testing Techniques
9.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Test Type, 2024-2030
- 9.6.1. HCV Antibody Testing
- 9.6.2. HCV Viral Load Testing
- 9.6.3. HCV Genotyping Testing
9.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2024-2030
- 9.7.1. Hospitals
- 9.7.2. Diagnostic Centers
- 9.7.3. Blood Donation Centers
9.8. Market Attractiveness Analysis

10. Middle East & Africa Hepatitis C Virus (HCV) Testing Market Outlook: Historical (2019-2023) and Forecast (2024-2030)

10.1. Key Highlights
10.2. Pricing Analysis
10.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2019-2023
- 10.3.1. By Country
- 10.3.2. By Technique
- 10.3.3. By Test Type
- 10.3.4. By End User
10.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2024-2030
- 10.4.1. GCC
- 10.4.2. Egypt
- 10.4.3. South Africa
- 10.4.4. Northern Africa
- 10.4.5. Rest of Middle East & Africa
10.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Technique, 2024-2030
- 10.5.1. Immunoassays-based Hepatitis C Virus Testing
- 10.5.2. Polymerase Chain Reaction-based (PCR) Hepatitis C Virus Testing
- 10.5.3. Other Hepatitis C Virus Testing Techniques
10.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Test Type, 2024-2030
- 10.6.1. HCV Antibody Testing
- 10.6.2. HCV Viral Load Testing
- 10.6.3. HCV Genotyping Testing
10.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2024-2030
- 10.7.1. Hospitals
- 10.7.2. Diagnostic Centers
- 10.7.3. Blood Donation Centers
10.8. Market Attractiveness Analysis

11. Competition Landscape

11.1. Market Share Analysis, 2024
11.2. Market Structure
- 11.2.1. Competition Intensity Mapping By Market
- 11.2.2. Competition Analog IC
- 11.2.3. Apparent Technique Capacity
11.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
- 11.3.1. OraSure Technologies, Inc.
  - 11.3.1.1. Overview
  - 11.3.1.2. Segments and Technique
  - 11.3.1.3. Key Financials
  - 11.3.1.4. Market Developments
  - 11.3.1.5. Market Strategy
- 11.3.2. Abbott Laboratories Inc.
  - 11.3.2.1. Overview
  - 11.3.2.2. Segments and Technique
  - 11.3.2.3. Key Financials
  - 11.3.2.4. Market Developments
  - 11.3.2.5. Market Strategy
- 11.3.3. Siemens Healthcare GmbH
  - 11.3.3.1. Overview
  - 11.3.3.2. Segments and Technique
  - 11.3.3.3. Key Financials
  - 11.3.3.4. Market Developments
  - 11.3.3.5. Market Strategy
- 11.3.4. Bio Rad Laboratories Inc.
  - 11.3.4.1. Overview
  - 11.3.4.2. Segments and Technique
  - 11.3.4.3. Key Financials
  - 11.3.4.4. Market Developments
  - 11.3.4.5. Market Strategy
- 11.3.5. Ortho Clinical Diagnostic Inc. (Johnson & Johnson)
  - 11.3.5.1. Overview
  - 11.3.5.2. Segments and Technique
  - 11.3.5.3. Key Financials
  - 11.3.5.4. Market Developments
  - 11.3.5.5. Market Strategy
- 11.3.6. Bayer AG
  - 11.3.6.1. Overview
  - 11.3.6.2. Segments and Technique
  - 11.3.6.3. Key Financials
  - 11.3.6.4. Market Developments
  - 11.3.6.5. Market Strategy
- 11.3.7. QIAGEN N.V.
  - 11.3.7.1. Overview
  - 11.3.7.2. Segments and Technique
  - 11.3.7.3. Key Financials
  - 11.3.7.4. Market Developments
  - 11.3.7.5. Market Strategy
- 11.3.8. Thermo Fisher Scientific Inc.
  - 11.3.8.1. Overview
  - 11.3.8.2. Segments and Technique
  - 11.3.8.3. Key Financials
  - 11.3.8.4. Market Developments
  - 11.3.8.5. Market Strategy
- 11.3.9. BioGenex
  - 11.3.9.1. Overview
  - 11.3.9.2. Segments and Technique
  - 11.3.9.3. Key Financials
  - 11.3.9.4. Market Developments
  - 11.3.9.5. Market Strategy
- 11.3.10. AccuQuick,
  - 11.3.10.1. Overview
  - 11.3.10.2. Segments and Technique
  - 11.3.10.3. Key Financials
  - 11.3.10.4. Market Developments
  - 11.3.10.5. Market Strategy
- 11.3.11. Roche Diagnostics (F. Hoffman-La Roche Ltd.)
  - 11.3.11.1. Overview
  - 11.3.11.2. Segments and Technique
  - 11.3.11.3. Key Financials
  - 11.3.11.4. Market Developments
  - 11.3.11.5. Market Strategy
- 11.3.12. STD Rapid Test Kits
  - 11.3.12.1. Overview
  - 11.3.12.2. Segments and Technique
  - 11.3.12.3. Key Financials
  - 11.3.12.4. Market Developments
  - 11.3.12.5. Market Strategy

12. Appendix

12.1. Research Methodology
12.2. Research Assumptions
12.3. Acronyms and Abbreviations